Hematopoietic stem cell transplantation can be used to treat thrombocytopenic purpura, but it is not usually the treatment of choice; the disease is primarily treated with blood component transfusions and medications.
Thrombocytopenic purpura is a common bleeding disorder, mostly related to immune factors. The treatment of this disease is mainly based on drugs, and drugs such as dexamethasone and gammaglobulin are commonly used in clinical practice.
For thrombocytopenic purpura with a high risk of bleeding, platelet transfusions can be given to improve coagulation. Hematopoietic stem cell transplantation is not the treatment of choice.
Hematopoietic stem cell transplantation may be considered for thrombocytopenic purpura that fails to respond to the above treatments, or for thrombocytopenic purpura that persists after splenectomy.
For thrombocytopenic purpura, it is recommended to go to the hospital in time; the above drugs should be used under the guidance of clinicians.